Financial
Latest full-year results from official filings.
FY2025 revenue $10.06bn (+20.5%); operating margin 29.3%; net income $2.86bn.
No debt; $9.03bn cash and investments.
- Official results release · Intuitive Surgical · 31 Dec 2025
Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
FY2025 revenue $10.06bn (+20.5%); operating margin 29.3%; net income $2.86bn.
No debt; $9.03bn cash and investments.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Aug 2026: The US Ninth Circuit revived an antitrust claim by Surgical Instrument Service Co. alleging Intuitive unlawfully controlled the aftermarket for da Vinci instruments, reversing a lower court ruling; the claims remain unproven.
Data breaches, cyber incidents, regulator action and assurance status.
Mar 2026: Intuitive disclosed a targeted phishing attack that exposed customer contact, employee and corporate data from internal business applications; it said da Vinci, Ion and digital platforms were not affected and the incident was contained. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
Dec 2025: Intuitive began a Class 2 recall of da Vinci S/Si Permanent Cautery Hook instruments after more complaints of frayed or broken pitch cables; FDA attributed the cause to process change control.
Contract delivery, go-lives, terminations and disputes.
No notable contract disputes, terminations or significant NHS/UK public sector contracts involving Intuitive Surgical found in HSH's search of the last 24 months.